Utah Medical Products (UTMD)
Makes specialty medical devices for labor, neonatal, gynecology, urology, and pressure-monitoring settings.
$71.79
At close+0.03 (+0.04%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 13 | 12 | 11 | 10 | 10 | 9 | 10 | 10 | 10 | 9 | 9 | 9 |
| Cost of revenue | 7 | 5 | 5 | 5 | 5 | 4 | 4 | 5 | 5 | 4 | 3 | 4 |
| Gross profit | 6 | 7 | 7 | 6 | 5 | 5 | 6 | 5 | 5 | 5 | 5 | 5 |
| 2 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 2 | |
| Research & development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2 | 11 | 1 | 2 | 2 | 8 | 1 | 2 | 2 | 2 | 3 | 2 | |
| Selling & marketing | 0 | 2 | 0 | 0 | 0 | 2 | 1 | 0 | 0 | 0 | 0 | 0 |
| General & administrative | 0 | 9 | 1 | 0 | 0 | 6 | 1 | 0 | 0 | 0 | 0 | 0 |
| Other expenses | 0 | −8 | 1 | 0 | 0 | −5 | 1 | 0 | 0 | 0 | 0 | 0 |
| Operating income | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 3 | 3 |
| 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
| Interest income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
| Other non-operating income | −1 | −1 | −1 | −1 | −1 | 0 | 0 | −1 | −1 | −1 | −1 | 0 |
| Income before tax | 5 | 5 | 5 | 4 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 |
| Income tax expense | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Net income from continuing operations | 4 | 4 | 4 | 3 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Net income | 4 | 4 | 4 | 3 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| EPS, basic | $1.08 | $1.18 | $1.09 | $0.98 | $1.02 | $0.86 | $0.92 | $0.94 | $0.82 | $0.80 | $0.82 | $0.84 |
| EPS, diluted | $1.08 | $1.18 | $1.09 | $0.98 | $1.02 | $0.86 | $0.92 | $0.94 | $0.82 | $0.80 | $0.82 | $0.84 |
| Weighted average shares, basic | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Weighted average shares, diluted | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| EBITDA | 7 | 6 | 5 | 5 | 5 | 4 | 4 | 5 | 4 | 4 | 4 | 3 |
| Depreciation & amortization | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
| EBIT | 5 | 5 | 5 | 4 | 4 | 3 | 3 | 4 | 3 | 3 | 3 | 3 |